Applying a next generation risk assessment framework for skin sensitisation to inconsistent new approach methodology information
ALTEX · 2023
DOI: 10.14573/altex.2211161 ↗Kurz gefasst
Fachartikel in der Zeitschrift ALTEX, 2023. Verfasst von Nicola Gilmour und 8 weiteren Autor:innen. Beteiligte Einrichtung: Unilever, Colworth Science Park, Bedford, United Kingdom. Hauptthemen laut MEDLINE: Animal Testing Alternatives, Cosmetics. Die Arbeit wurde bisher 9-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unilever, Colworth Science Park, Bedford, United Kingdom.
- L'Oréal, Research & Innovation, Aulnay-sous-Bois, France.
- seh consulting + services, Paderborn, Germany.
- Procter & Gamble Services NV/SA, Strombeek-Bever, Belgium.
- Innovitox Consulting & Services, Houten, The Netherlands.
- L'Oréal, Research & Innovation, Clichy, France.
Zitieren
APA
Gilmour, N., Alépée, N., Hoffmann, S., Kern, P. S., Van Vliet, E., Bury, D., Miyazawa, M., Nishida, H., & Cosmetics Europe (2023). Applying a next generation risk assessment framework for skin sensitisation to inconsistent new approach methodology information. ALTEX. https://doi.org/10.14573/altex.2211161
Vancouver
Gilmour N, Alépée N, Hoffmann S, Kern PS, Van Vliet E, Bury D, et al. Applying a next generation risk assessment framework for skin sensitisation to inconsistent new approach methodology information. ALTEX. 2023. doi:10.14573/altex.2211161
BibTeX
@article{Gilmour2023,
author = {Gilmour, Nicola and Alépée, Nathalie and Hoffmann, Sebastian and Kern, Petra S and Van Vliet, Erwin and Bury, Dagmar and Miyazawa, Masaaki and Nishida, Hayato and Cosmetics Europe},
title = {Applying a next generation risk assessment framework for skin sensitisation to inconsistent new approach methodology information},
journal = {ALTEX},
year = {2023},
doi = {10.14573/altex.2211161}
}
EUVIMED